Idelalisib 100 mg, 150 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 100 mg, 150 mg

Reference Brands: Zydelig (EU/UK/India)

Category: Oncology Cancer Care

Idelalisib is a Oncology Cancer Care product available as Tablets in strengths 100 mg, 150 mg. It corresponds to the reference brand Zydelig (EU/UK/India). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Idelalisib is an oral targeted anticancer medication used in the treatment of certain hematologic malignancies, particularly B-cell cancers. It is primarily indicated for patients with relapsed chronic lymphocytic leukemia (CLL) and is often administered in combination with rituximab when previous treatments have not been effective. Idelalisib is also used for relapsed follicular lymphoma and small lymphocytic lymphoma in patients who have received prior therapies.

Idelalisib works by selectively inhibiting the phosphoinositide 3-kinase delta (PI3K-δ) enzyme, a key component of a signaling pathway that promotes the growth, survival, and migration of malignant B-cells. By blocking this pathway, the drug helps slow the progression of cancer cells and may induce their death, thereby improving disease control in affected patients.

Idelalisib belongs to the class of medicines known as kinase inhibitors and represents an important advancement in targeted cancer therapy. It is marketed under the brand name Zydelig and is available in oral tablet form. Due to its targeted mechanism of action, Idelalisib has become a valuable treatment option in modern oncology, particularly for patients who require alternative therapies after relapse or resistance to conventional treatments.